A new trading day began on Monday, with Oncolytics Biotech, Inc (NASDAQ: ONCY) stock price down -7.06% from the previous day of trading, before settling in for the closing price of $0.99. ONCY’s price has ranged from $0.33 to $1.51 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 23.13% over the past five years. Meanwhile, its annual earnings per share averaged 10.34%. With a float of $98.71 million, this company’s outstanding shares have now reached $103.64 million.
Oncolytics Biotech, Inc (ONCY) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Oncolytics Biotech, Inc is 1.64%, while institutional ownership is 2.81%.
Oncolytics Biotech, Inc (ONCY) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.1 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 10.34% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.45% during the next five years compared to 23.13% growth over the previous five years of trading.
Oncolytics Biotech, Inc (NASDAQ: ONCY) Trading Performance Indicators
Here are Oncolytics Biotech, Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.84.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.28, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.24 in one year’s time.
Technical Analysis of Oncolytics Biotech, Inc (ONCY)
Oncolytics Biotech, Inc (NASDAQ: ONCY) saw its 5-day average volume 0.47 million, a negative change from its year-to-date volume of 0.98 million. As of the previous 9 days, the stock’s Stochastic %D was 64.02%.
During the past 100 days, Oncolytics Biotech, Inc’s (ONCY) raw stochastic average was set at 17.32%, which indicates a significant decrease from 32.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0653 in the past 14 days, which was lower than the 0.0835 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0871, while its 200-day Moving Average is $0.8823. Nevertheless, the first resistance level for the watch stands at $0.9886 in the near term. At $1.0543, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.0885. If the price goes on to break the first support level at $0.8887, it is likely to go to the next support level at $0.8545. The third support level lies at $0.7888 if the price breaches the second support level.
Oncolytics Biotech, Inc (NASDAQ: ONCY) Key Stats
With a market capitalization of 99.32 million, the company has a total of 100,361K Shares Outstanding. Currently, annual sales are 0 K while annual income is -23,140 K. The company’s previous quarter sales were 0 K while its latest quarter income was -10,450 K.
